Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. Filtered by score tier "Elite", market cap "Mid $2–10B", No report yet: 70 match(clear filters).

# Ticker Mkt Cap Score Baillie 10Y ROE Profit Streak Net Debt/Eq Gross Margin Report FY
1 Rightmove PLC RMV · LSE $4.4B
94/100 Elite
60.0%low 60.0% 10 yr+ Net cash 100% FY2025
2 Nemetschek AG O.N. NEM · XETRA $7.2B
93/100 Elite
26.3%low 19.4% 10 yr+ 0.2× 53% FY2025
3 MarketAxess Holdings Inc MKTX · US $5.7B
93/100 Elite
25.1%low 19.7% 10 yr+ Net cash 77% FY2025
4 Shenzhen New Industries Biomedical 300832 · Shenzhen $5.3B
93/100 Elite
23.5%low 17.4% 10 yr+ Net cash 75% FY2025
5 Proya Cosmetics Co Ltd Class A 603605 · Shanghai $3.3B
93/100 Elite
22.1%low 13.8% 10 yr+ Net cash 66% FY2025
6 Genpact Limited G · US $5.1B
92/100 Elite
20.4%low 16.8% 10 yr+ 0.2× 36% FY2025
7 Zhejiang Weixing New Building Materials Co Ltd 002372 · Shenzhen $2.0B
92/100 Elite
23.9%low 15.2% 10 yr+ Net cash 43% FY2025
8 Jiangsu King's Luck Brewery Joint-Stock Co Ltd 603369 · Shanghai $5.0B
91/100 Elite
19.7%low 15.7% 10 yr+ Net cash 74% FY2025
9 Hubei Jumpcan Pharmaceutical Co Ltd 600566 · Shanghai $3.4B
91/100 Elite
21.6%low 12.2% 10 yr+ Net cash 83% FY2025
10 IMI PLC IMI · LSE $8.8B
90/100 Elite
24.4%low 21.3% 10 yr+ 0.5× 45% FY2025
11 Chemed Corp CHE · US $7.1B
90/100 Elite
29.2%low 18.2% 10 yr+ 0.1× 33% FY2025
12 Howden Joinery Group Plc HWDN · LSE $5.5B
90/100 Elite
32.1%low 20.5% 10 yr+ 0.3× 62% FY2025
13 Ninety One PLC N91 · LSE $2.7B
90/100 Elite
51.3%low 21.9% 10 yr+ Net cash 64% FY2026
14 Hangzhou Robam Appliances Co Ltd 002508 · Shenzhen $2.1B
90/100 Elite
19.8%low 10.9% 10 yr+ Net cash 53% FY2025
15 Yealink Network Technology Corp Ltd 300628 · Shenzhen $6.9B
89/100 Elite
28.7%low 20.6% 10 yr+ Net cash 67% FY2025
16 MSC Industrial Direct Company Inc MSM · US $6.9B
89/100 Elite
20.2%low 14.4% 10 yr+ 0.3× 42% FY2025
17 Gentex Corporation GNTX · US $5.0B
89/100 Elite
18.6%low 15.4% 10 yr+ Net cash 36% FY2025
18 Grand Canyon Education Inc LOPE · US $3.8B
89/100 Elite
23.3%low 16.3% 10 yr+ Net cash 52% FY2025
19 Anhui Gujing Distillery Co Ltd 000596 · Shenzhen $7.0B
88/100 Elite
18.6%low 13.9% 10 yr+ Net cash 77% FY2025
20 Computacenter PLC CCC · LSE $6.1B
88/100 Elite
20.0%low 14.9% 10 yr+ Net cash 14% FY2025
21 Qualys Inc QLYS · US $5.1B
88/100 Elite
24.2%low 7.4% 10 yr+ Net cash 79% FY2025
22 Rotork PLC ROR · LSE $5.0B
88/100 Elite
16.4%low 12.2% 10 yr+ Net cash 46% FY2025
23 Cohen & Steers Inc CNS · US $4.2B
88/100 Elite
40.2%low 27.3% 10 yr+ Net cash 50% FY2025
24 Toro Co TTC · US $8.7B
87/100 Elite
32.6%low 21.8% 10 yr+ 0.5× 35% FY2025
25 Brady Corporation BRC · US $4.5B
87/100 Elite
14.9%low 12.1% 10 yr+ Net cash 50% FY2025
26 Anhui Yingjia Distillery Co Ltd 603198 · Shanghai $4.4B
87/100 Elite
21.0%low 16.2% 10 yr+ Net cash 66% FY2025
27 HLA GROUP CORP LTD 600398 · Shanghai $4.2B
87/100 Elite
19.8%low 11.8% 10 yr+ Net cash 39% FY2025
28 Plus500 Ltd PLUS · LSE $3.3B
87/100 Elite
52.0%low 38.8% 10 yr+ Net cash 100% FY2025
29 Indutrade AB INDT · ST $9.3B
86/100 Elite
19.6%low 15.0% 10 yr+ 0.4× 34% FY2025
30 Hebei Yangyuan ZhiHui Beverage Co Ltd 603156 · Shanghai $6.8B
86/100 Elite
21.0%low 12.8% 10 yr+ Net cash 48% FY2025
31 Zhejiang Supor Co Ltd 002032 · Shenzhen $4.8B
86/100 Elite
28.8%low 23.7% 10 yr+ Net cash 26% FY2025
32 RS GROUP PLC RS1 · LSE $4.3B
86/100 Elite
19.3%low 11.3% 10 yr+ 0.2× 43% FY2026
33 Livzon Pharmaceutical Group Inc 000513 · Shenzhen $3.9B
86/100 Elite
16.0%low 10.2% 10 yr+ Net cash 63% FY2025
34 YETI Holdings Inc YETI · US $3.7B
86/100 Elite
35.8%low 17.0% 10 yr+ 0.1× 53% FY2025
35 Shanghai M&G Stationery Inc 603899 · Shanghai $3.0B
86/100 Elite
20.8%low 14.1% 10 yr+ Net cash 23% FY2025
36 Buckle Inc BKE · US $2.3B
86/100 Elite
39.8%low 22.8% 10 yr+ 0.3× 46% FY2026
37 IG Group Holdings PLC IGG · LSE $6.1B
85/100 Elite
22.8%low 16.3% 10 yr+ Net cash 90% FY2025
38 Vontier Corp VNT · US $4.5B
85/100 Elite
40.2%low 21.4% 10 yr+ 1.3× 45% FY2025
39 Acuity Brands Inc AYI · US $9.8B
84/100 Elite
17.1%low 11.7% 10 yr+ 0.2× 43% FY2025
40 Elisa Oyj ELISA · HE $6.1B
84/100 Elite
28.4%low 26.4% 10 yr+ 1.2× 62% FY2025
41 Fuchs Petrolub SE Preference Shares FPE3 · XETRA $5.7B
84/100 Elite
16.6%low 13.9% 10 yr+ Net cash 34% FY2025
42 G-bits Network Technology Xiamen Co Ltd 603444 · Shanghai $3.9B
84/100 Elite
28.1%low 19.3% 10 yr+ Net cash 90% FY2025
43 Jiangzhong Pharmaceutical Co Ltd 600750 · Shanghai $2.3B
84/100 Elite
15.8%low 12.2% 10 yr+ Net cash 66% FY2025
44 Jafron Biomedical Co Ltd 300529 · Shenzhen $2.1B
84/100 Elite
23.3%low 13.9% 10 yr+ Net cash 83% FY2025
45 Huadong Medicine Co Ltd 000963 · Shenzhen $7.1B
83/100 Elite
17.6%low 13.5% 10 yr+ Net cash 30% FY2025
46 Morgan Sindall Group PLC MGNS · LSE $2.6B
83/100 Elite
17.5%low 10.8% 10 yr+ Net cash 11% FY2025
47 Landstar System Inc LSTR · US $5.9B
82/100 Elite
30.3%low 14.5% 10 yr+ Net cash 20% FY2025
48 Trex Company Inc TREX · US $4.5B
82/100 Elite
33.1%low 18.4% 10 yr+ 0.2× 40% FY2025
49 Chongqing Brewery Co Ltd 600132 · Shanghai $3.1B
82/100 Elite
49.8%low 14.7% 10 yr+ Net cash 46% FY2025
50 Dashenlin Pharm Grp Co Ltd 603233 · Shanghai $3.0B
82/100 Elite
18.2%low 13.3% 10 yr+ 0.0× 38% FY2025
51 CSG Systems International Inc CSGS · US $2.3B
82/100 Elite
20.0%low 12.4% 10 yr+ 1.4× 48% FY2025
52 Demant A/S DEMANT · CO $9.2B
81/100 Elite
21.9%low 13.6% 10 yr+ 2.3× 74% FY2025
53 Spirax Group plc SPX · LSE $6.5B
81/100 Elite
20.6%low 13.4% 10 yr+ 0.5× 50% FY2025
54 Shanghai Friendess Electronics Tech 688188 · Shanghai $5.9B
81/100 Elite
27.3%low 11.2% 10 yr+ Net cash 82% FY2025
55 Huali Industrial Group Company Limited 300979 · Shenzhen $5.8B
81/100 Elite
30.9%low 19.7% 9 yr Net cash 23% FY2025
56 Temenos Group AG TEMN · SW $5.7B
81/100 Elite
36.0%low 19.7% 10 yr+ 1.2× 70% FY2025
57 Hisense Kelon Electrical Holdings Co Ltd 000921 · Shenzhen $5.3B
81/100 Elite
19.1%low 9.4% 10 yr+ Net cash 21% FY2025
58 Lancaster Colony Corporation LANC · US $4.8B
81/100 Elite
17.8%low 10.6% 10 yr+ Net cash 24% FY2024
59 Royal Unibrew A/S RBREW · CO $3.6B
81/100 Elite
29.8%low 19.1% 10 yr+ 0.9× 48% FY2025
60 Shanghai Huace Navigation Technology Ltd 300627 · Shenzhen $3.2B
81/100 Elite
17.0%low 12.2% 10 yr+ Net cash 60% FY2025
61 The Marzetti Company MZTI · US $2.9B
81/100 Elite
17.7%low 10.6% 10 yr+ Net cash 24% FY2025
62 AIMA Technology Group Co Ltd 603529 · Shanghai $2.7B
81/100 Elite
25.4%low 13.3% 10 yr+ Net cash 15% FY2025
63 Dino Polska SA DNP · WAR $8.6B
80/100 Elite
24.2%low 18.0% 10 yr+ Net cash 24% FY2025
64 Edenred SA EDEN · Paris $7.3B
80/100 Elite
60.0%low 60.0% 10 yr+ 48% FY2025
65 China Resources Sanjiu Medical & Pharmaceutical Co Ltd 000999 · Shenzhen $6.0B
80/100 Elite
14.4%low 11.6% 10 yr+ Net cash 60% FY2025
66 Auto Trader Group plc AUTO · LSE $5.2B
80/100 Elite
51.1%low 27.9% 10 yr+ 0.5× 91% FY2026
67 Frontdoor Inc FTDR · US $5.1B
80/100 Elite
49.5%low 22.1% 10 yr+ 2.7× 47% FY2025
68 Badger Meter Inc BMI · US $3.9B
80/100 Elite
15.1%low 9.2% 10 yr+ Net cash 39% FY2025
69 Jiangsu Nhwa Pharmaceutical Co Ltd 002262 · Shenzhen $3.1B
80/100 Elite
16.2%low 13.1% 10 yr+ Net cash 66% FY2025
70 Artisan Partners Asset Management Inc APAM · US $2.8B
80/100 Elite
58.6%low 45.9% 10 yr+ 0.4× 49% FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.